Control of cardiovascular risk factors

1 paper3 findings

Outcomes

Cardiovascular mortality

no changein humans1

1 study

Control of cardiovascular risk factors have no effect on cardiovascular mortality in humans.
“However, these associations were not found in CKM stage 3 and stage 4.”
Humansin CKM stage 3 and stage 4
The relationship between cardiovascular risk factors control and all-cause or cardiovascular mortality across different cardiovascular-kidney-metabolic syndrome stages: Insights from NHANES 2005-2018
AHA Scientific Sessions 2025 abstract3 Nov 2025

Cardiovascular mortality

downin humans1HR 0.157

1 study

Control of cardiovascular risk factors lower the risk of cardiovascular mortality in humans (HR 0.157, 95% CI 0.029-0.859).
“had a significantly lower risk of all-cause mortality [HR(95%CI): 0.406 (0.199, 0.832)] and cardiovascular mortality [HR(95%CI): 0.157 (0.029, 0.859)].”
Humansin CKM stages 0 and 1, compared to 1 risk factor controlled
The relationship between cardiovascular risk factors control and all-cause or cardiovascular mortality across different cardiovascular-kidney-metabolic syndrome stages: Insights from NHANES 2005-2018
AHA Scientific Sessions 2025 abstract3 Nov 2025

Mortality

downin humans1HR 0.406

1 study

Control of cardiovascular risk factors lower the risk of mortality in humans (HR 0.406, 95% CI 0.199-0.832).
“For the population in CKM stages 0 and 1, compared to the 1 risk factors controlled group, the population with 3 risk factors controlled had a significantly lower risk of all-cause mortality”
Humansin CKM stages 0 and 1, compared to 1 risk factor controlled
The relationship between cardiovascular risk factors control and all-cause or cardiovascular mortality across different cardiovascular-kidney-metabolic syndrome stages: Insights from NHANES 2005-2018
AHA Scientific Sessions 2025 abstract3 Nov 2025

1 in 12 months

AHA Scientific Sessions 2025 Abstract3 Nov